DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» DHAP (chemotherapy)
DHAP (chemotherapy)
Primary Mediastinal Large B-Cell Lymphoma
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines® ) Non-Hodgkin’S Lymphomas Version 2.2015
Drug Resistance in Non-Hodgkin Lymphomas
Poor Mobilization Is an Independent Prognostic Factor in Patients with Malignant Lymphomas Treated by Peripheral Blood Stem Cell Transplantation
Two Cases with CD-20 Negative Diffuse Large B-Cell Lymphoma and Literature Review
Targeted Drugs As Maintenance Therapy After Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma
The Role of Glucocorticoids in the Treatment of Non-Hodgkin Lymphoma
Modified DHAP Regimen in the Salvage Treatment of Refractory Or
Mechanisms of Resistance to Monoclonal Antibodies (Mabs) in Lymphoid Malignancies
Peripheral T-Cell Lymphoma
Sequential Chemotherapy by CHOP and DHAP Regimens Followed By
Pdf 291.42 K
Ofatumumab, a Second- Generation Anti-CD20 Monoclonal Antibody, For
Combination Therapy with Brentuximab Vedotin and Cisplatin/Cytarabine in a Patient with Primarily Refractory Anaplastic Lymphoma
NCCN Guidelines for Patients Diffuse Large B-Cell Lymphoma
The Effects of Cancer Treatment on Reproductive Functions. Guidance on Management
Minimal Renal Toxicity After Rituximab DHAP with a Modified Cisplatin Application Scheme in Patients with Relapsed Or Refractory Diffuse Large B- Cell Lymphoma
Novel Therapies for Relapsed Or Refractory Diffuse Large B-Cell Lymphoma
Top View
Therapeutic Updates for Relapsed and Refractory Classical Hodgkin Lymphoma
Outcomes of Diffuse Large B-Cell Lymphoma Patients Relapsing After Autologous Stem Cell Transplantation: an Analysis of Patients Included in the CORAL Study
Ifosfamide Inclusion.Pdf